Hear from the Plenary Speakers

Why is Precision Medicine Critical for Supportive Care in Cancer?


Joanne Bowen

“Harnessing technology to target personalised supportive care maximises positive outcomes for individuals and their community.”

Janet Coller

"In a perfect world, cancer treatment would provide optimal benefit with minimal risk of adverse effects. Precision medicine uses technology to strive for these improved clinical outcomes through tailoring treatment and supportive care for all people."

Why is Financial Toxicity Critical for Supportive Care in Cancer?

​Pricivel Carrera


“Combined with the anxiety and discomfort over their cancer experience, the patient with cancer faces financial distress with mounting cancer-related expenditures alongside loss in income. The potentially ruinous impact of cancer treatment on the individual patient and their household’s well-being make financial toxicity an important challenge and opportunity in the provision of supportive care.”


Jonas de Souza

“Financial toxicity should be identified, measured and treated, similar to what we do with other side-effects.” 

​Ronan Kelly

“Patients have indicated that personal responsibility for cost does increase their sensitivity to the value of treatments they are being prescribed but discussing costs at this extremely stressful time when patients can feel overwhelmed is very challenging”. 

Why is Understanding the Side Effects of Immunotherapy Critical for Supportive Care in Cancer?


Joel Epstein

"new therapies, no toxicities"


Mario Lacouture

“Prevention and management of adverse events resulting from immunotherapies are increasingly important, as they are used in earlier stages of disease, in combination with other agents resulting in grater toxicities, and as patients live longer, quality of life issues are paramount” 




Keep Me Updated